MYD88 and ovarian carcinoma: First, p53 can activate the MyD88-dependent Toll-like receptor signaling pathway, which is thought to promote inflammation and resistance to apoptosis and to induce a stem-like phenotype during the progression of cancers such as ovarian cancer [58, 59].